Rani Therapeutics has now raised $142m in total, its latest investors including GV, Ping An Ventures, GeneScience, AstraZeneca, Shire and Novartis.

Highlander Venture Fund has made its second investment, selecting Sensorygen as its latest portfolio company.

Ping An Ventures is raising a total of $1.3bn for two life sciences-focused fund: $500m for a dollar-denominated fund and $800m for a renminbi-denominated one.

The Penn State spinout has received funding from Pennsylvania state-backed investors to develop a treatment for diabetic dry eye disease.

Princeton University is set to open an incubator and co-working affiliate of BioLabs with room for 25 startups in April.

Based on research at Stanford University, Zenflow is developing medical devices to treat obstructive urinary symptoms.

The Maryland Momentum Fund has made its second investment, providing $250,000 to NextStep Robotics.

The infant disease screening system developer has raised $12.8m according to a securities filing, four months after a $10m round backed by BOE and Rex Healthcare.